Peer Review History
| Original SubmissionJune 3, 2025 |
|---|
|
Dear Dr. Chisompola, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Muhammad Abbas Abid, MD Academic Editor PLOS ONE Satff Editor comments: Please correct the term monkeypox into Mpox in the title. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. I3. f the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Even though it is a KAP study, the study is important as knowledge about mpox is still limited. Yet, there are a number of changes required before it becomes a holistic and interesting read. The study results cannot be generalized to all healthcare professionals as most of the included participants technologists. The limitations section should be added upon and the reviewer comments incorporated to make it a more comprehensive read. Good luck to the authors! [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1. The manuscript labels 46.5% knowledge accuracy as “moderate” without establishing any theoretical or empirical justification for that classification. There is no engagement with literature that defines meaningful thresholds for knowledge adequacy in healthcare preparedness contexts. This subjective categorization reduces the interpretive clarity of the findings. The authors should support their classifications using references to similar KAP studies or global health benchmarks to ensure their descriptors have an objective basis and allow readers to assess the severity of the observed gaps with greater precision. 2. The finding that 76.4% of participants could not correctly identify Mpox transmission modes is significant, yet the paper does not probe the reasons for this widespread misconception. There is no exploration of the sources participants rely on for infectious disease information or whether misinformation might play a role. As a result, the implications of this gap are left underdeveloped. The discussion could be improved by analyzing potential systemic contributors to poor knowledge, such as lack of access to continuing education or the influence of low-quality digital health content, especially in low-resource environments. 3. The sample is heavily skewed, with 63.6% of respondents being laboratory technologists or scientists. Despite this imbalance, the authors generalize their findings across all healthcare professionals in Zambia. Such overrepresentation introduces substantial bias, especially in measuring practices and attitudes, as lab personnel may differ in their patient interaction frequency. A more appropriate approach would involve stratified results or a weighting mechanism to ensure that the findings reflect Zambia’s broader healthcare workforce demographics more accurately. 4. A key limitation of this study is its omission of the influence that online health content and misinformation may have on healthcare professionals' Mpox-related knowledge and practices. The findings are discussed in isolation from the digital information environment that increasingly shapes professional awareness and response to emerging diseases. This narrows the scope of the analysis and limits its utility for training design. To address this, it is suggested that the authors review recent works such as https://doi.org/10.1109/CCWC62904.2025.10903713 and https://doi.org/10.1109/AiDAS63860.2024.10730443, which show how exposure to sentiment and toxicity in online platforms affects health discourse, and can inform how preparedness programs should adapt to the realities of information ecosystems. 5. There are unresolved concerns about participant anonymity and data integrity. The paper claims that duplicate responses were prevented via email verification, yet also states that all data were collected anonymously. This contradiction raises questions about how the research balanced verification with participant privacy, especially given the use of a Google Form. The authors need to clarify the process, explicitly stating how identity verification was managed without violating ethical principles of anonymity, particularly in light of the sensitive nature of self-reported practices. Reviewer #2: The study is well formatted and methodologically sound and provides interesting insights into the levels of preparedness of health workers in Zambia, so that training resources can be improved. MAJOR COMMENTS: 1. Line 52: The mode of transmission described as ‘direct transmission’ is unclear, it would be better described as something along the following lines: ‘direct contact with a person with the virus’, and maybe with the addition that this occurs through skin lesions, body fluids.... 2. Discussion: You could introduce more commentary on the results than simply comparing data from other studies but try to give some kind of explanation for the findings based on the literature. 3. Strengths and limitations: Mention a possible bias of selection related to people responding, with the language, cause participants should understand English and this could imply a greater formative capacity and overestimate some values. MINOR COMMENTS: 1. Line 15: error in the correspondent's e-mail address (p.2): Should correct “gmai.com” to “gmail.com.” 2. Line 50: Orthopoxvirus, all together, instead Ortho poxvirus ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Inés Armenteros-Yeguas ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Knowledge, Attitudes, and Practices Toward Mpox Among Laboratory Professionals in Zambia: A Cross-Sectional Study PONE-D-25-30146R1 Dear Dr. Chisompola, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Muhammad Abbas Abid, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-30146R1 PLOS ONE Dear Dr. Chisompola, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Muhammad Abbas Abid Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .